Rosa Elvira Nuñez-Anita

Prof. Dr. Rosa Elvira Nuñez-Anita

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2012 in Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
AMAura-Ileana Moreno-Vega
Aura-Ileana Moreno-Vega
TGTeresa Gómez-Quintero
Teresa Gómez-Quintero
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
LALaura Susana Acosta-Torres
Laura Susana Acosta-Torres
Victor CastanoVictor Castano
Victor Castano
Materials in the nanometer size range may possess unique and beneficial properties, which are very useful for different medical applications including stomatology, pharmacy, and implantology tissue engineering. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. Polymeric and ceramic nanoparticles have been extensively studied as particulate carriers in the pharmaceutical and medical fields, because they show promise as drug delivery systems as a result of their controlled- and sustained-release properties, subcellular size, and biocompatibility with tissue and cells. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents. Nanotechnology is showing promising developments in many areas and may benefit our health and welfare. However, a wide range of ethical issues has been raised by this innovative science. Many authorities believe that these advancements could lead to irreversible disasters if not limited by ethical guidelines.

1 September 2012 in International Journal of Nanomedicine
Verified
Journal Article
Open access
LALaura Susana Acosta-Torres
Laura Susana Acosta-Torres
IMIrasema Mendieta
Irasema Mendieta
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
MCMarcos Cajero-Juárez
Marcos Cajero-Juárez
Victor CastanoVictor Castano
Victor Castano
Peer reviewed article authored by (Acosta-Torres LS, Mendieta I, Nuñez-Anita RE, Cajero-Juárez M, Castaño VM). Read article or submit your manuscript for publishing.

3 October 2010 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
LALaura Susana Acosta-Torres
Laura Susana Acosta-Torres
LLLuz M. López-Marín
Luz M. López-Marín
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
GHGenoveva Hernández-Padrón
Genoveva Hernández-Padrón
VCVictor M. Castaño
Victor M. Castaño
Nowadays, most products for dental restoration are produced from acrylic resins based on heat-cured Poly(Methyl MethAcrylate) (PMMA). The addition of metal nanoparticles to organic materials is known to increase the surface hydrophobicity and to reduce adherence to biomolecules. This paper describes the use of nanostructured materials, TiO2and Fe2O3, for simultaneously coloring and/or improving the antimicrobial properties of PMMA resins. Nanoparticles of metal oxides were included during suspension polymerization to produce hybrid metal oxides-alginate-containing PMMA. Metal oxide nanoparticles were characterized by dynamic light scattering, and X-ray diffraction. Physicochemical characterization of synthesized resins was assessed by a combination of spectroscopy, scanning electron microscopy, viscometry, porosity, and mechanical tests. Adherence ofCandida albicanscells and cellular compatibility assays were performed to explore biocompatibility and microbial adhesion of standard and novel materials. Our results show that introduction of biocompatible metal nanoparticles is a suitable means for the improvement of conventional acrylic dental resins.

17 September 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
Mario Nava-VillalbaMario Nava-Villalba
Mario Nava-Villalba
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
ABAlexander Bontempo
Alexander Bontempo
CACarmen Aceves
Carmen Aceves
Molecular iodine (I2) exhibits antiproliferative and apoptotic effects on in vivo and in vitro cancer models. These effects are thought to be mediated by an iodinated arachidonic acid derivative, 6-iodolactone (6IL), and one of the proposed mechanisms is that 6IL activates Peroxisome Proliferator-Activated Receptors type gamma (PPARG). These receptors have been implicated in the inhibition of carcinogenic processes, in addition to their classical role in maintaining lipid and glucose homeostasis. The aim of this study was to determine whether PPARG participates in the 6IL antiproliferative and apoptotic effects on the mammary cancer cell line MCF-7. The 6IL/PPARG complex was inhibited by the PPARG antagonist GW9662, in both an endogenous and overexpressed (adenoviral vector infection) context, and stable PPARG-knockdown MCF-7 cells (RNA interference, confirmed with hydrolysis probes and Western blot), were used to corroborate the PPARG participation. 6IL effects on proliferation (measured by Trypan Blue exclusion) and apoptosis (phosphatidylserine identification by flow cytometer) were evaluated in conditions of chemical inhibition (GW9662) and silencing (RNA interference). A wound-healing assay was conducted on wild-type and stable PPARG-knockdown MCF-7 cells to evaluate the antimigrational effect of 6IL. Caspase-8 activity was evaluated to determine if the extrinsic pathway is involved in the effects of 6IL and I2 treatment. Antiproliferative and pro-apoptotic 6IL effects require the activation of PPARG. In addition, wound-healing assays show that 6IL is able to inhibit MCF-7 cell migration and that PPARG plays a role in this phenomenon. Finally, the data exclude the participation of the extrinsic apoptotic pathway in 6IL- and I2-induced apoptosis. These results support the previously proposed mechanism, in which the I2 effects are mediated by 6IL, and they provide further support for the use of I2 as coadjuvant in breast cancer treatment.

26 May 2020 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
FDFrancisco Perez Duran
Francisco Perez Duran
LALaura Susana Acosta-Torres
Laura Susana Acosta-Torres
PSPaloma Serrano-Diaz
Paloma Serrano-Diaz
ITIrma Arcelia Toscano-Torres
Irma Arcelia Toscano-Torres
IOIngrid Brenda Olivo-Zepeda
Ingrid Brenda Olivo-Zepeda
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
Bacterial contamination in swine semen affects the quality and longevity of sperm and consequently fertility is reduced. Antibiotics have been used to prevent bacterial growth, but the frequency of...

24 August 2021 in Viruses
Verified
Journal Article
Open access
PDF file
RCRicarda Cortés-Vieyra
Ricarda Cortés-Vieyra
SGSergio Gutiérrez-Castellanos
Sergio Gutiérrez-Castellanos
CACleto Alvarez-Aguilar
Cleto Alvarez-Aguilar
VBVictor Manuel Baizabal-Aguirre
Victor Manuel Baizabal-Aguirre
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
AGAnel Gomez Garcia
Anel Gomez Garcia
Knowledge about the immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, particularly regarding the function of eosinophils, has been steadily emerging recently. There exists controversy regarding the implications of eosinophils in the coronavirus disease 2019 (COVID-19)’s pathology. We report a retrospective cohort study including the comparison of leukocyte counts in COVID-19 patients, considering the outcomes of recovery (n = 59) and death (n = 60). Among the different types of leukocytes, the eosinophil counts were those that showed the greatest difference between recovered and deceased patients. Eosinopenia (eosinophil count < 0.01 × 109/L) was more frequently observed in deceased than recovered patients (p = 0.0012). The eosinophil counts more rapidly increased and showed a greater proportion over the course of the disease in the recovered than deceased patients. Furthermore, the estimated survival rate was greater in patients without eosinopenia than in patients with eosinopenia (p = 0.0070) during hospitalization. Importantly, recovered but not deceased patients showed high negative correlations of the eosinophils with the neutrophil-to-lymphocyte ratio (NLR) and neutrophil counts at Day 9 of the onset of clinical symptoms (p ≤ 0.0220). Our analysis suggests that eosinopenia may be associated with unfavorable disease outcomes and that the eosinophils have a beneficial function in COVID-19 patients, probably contributing by controlling the exacerbated inflammation induced by neutrophils.